Startup Signup
Opportunity for Early-Stage Start-Ups in front of the Right Investors at the Right Time
Join us for our Fall 2025 Investor Meetings - Hosted Remotely
Click here to view all the startups that had the opportunity to attend and present at a HIP investor meeting or have received funding and advisory services
Our goals for the Startup community are simple
Save you time
Go through our expedited process of due diligence which includes getting exposed to our clinical, technology and subject matter experts. We prep you to concisely present your value proposition to a group of curated investors, advisors, and experts.
Bring you the right investors
As we perform our due diligence, we curate the optimal investors from our ever-growing investor network, to hear your value proposition. Pitch to those who are passionate about your area of interest.
Connect safely
HIP investor network members provide invaluable real-time feedback and a formal diligence report after your meeting. We also facilitate follow-up conversations and deeper dives based on the outcomes.
What you can expect before, during and after the investor meeting
Before
Complete our sign-up and application process to see if you qualify to present at a HIP investor meeting.
During
Opportunity to present your company to a highly curated, healthcare-focused network of investors, advisors, and experts, and engage in a dynamic real-time Q&A to gain valuable insights.
After
Gain access to formal diligence feedback and the opportunity to continue conversations with a clear roadmap and report—so you know exactly where we stand.
Here's how to get started
Step 1
Fill it out the information form below
Step 2
After screening and review, we will invite you to the formal application process
Step 3
Get selected and kickstart your diligence process with a HIP investor meeting
Frequently asked questions
HIP is an opportunistic, healthcare-only venture capital firm built with and for a community of seasoned investors—both non-institutional (angels, family offices, physicians) and institutional (VCs, health systems, strategics). We screen and invite startups to begin their investment journey by presenting at one of our Investor Meetings. Check out the About Us page to learn more about HIP.
HIP is more than a healthcare venture capital firm—we are a full lifecycle partner. We stay actively involved with our portfolio companies, providing advisory, commercial, and exit support. In addition, we engage healthcare experts (who are also investors) to guide the entire investment and post-investment process.
Investor meetings are held virtually to accommodate investors across multiple time zones. From time to time, we also host in-person meetings.
There is no fee to participate in the process or to present. However, if we invest, there is a required (non-negotiable) advisory agreement. The structure of this agreement is tied to the investment amount and subject to negotiated factors.
Startups should have investor-ready materials prepared and be able to clearly articulate their value proposition. We also provide templates to support you as part of the application process.
We focus exclusively on healthcare. Our investments include digital health, health tech, tech-enabled services, health IT, and life sciences (medical devices, diagnostics, and screening).
We do not invest in drug discovery, drug development, or biotechnology.
Startups need to complete the following steps:
1. Fill out the contact form.
2. If there is alignment, we will invite you to the application process.
3. The completed application folder is reviewed by our selection committee.
4. Selected startups are invited to present at an investor meeting.
HIP is opportunistic in its approach. Our first checks typically target Seed through Series A, though we also consider growth and late-stage startups. For more details, visit our About Us page.
Meetings are attended by members of the HIP investor network, which includes healthcare venture capital firms, strategics (health systems, payors, corporates), non-institutional investors (operators, healthcare executives, physicians), and high-net-worth individuals/family offices.
Our investors remain confidential until the investor meeting. Companies are not permitted to contact them before or after the event unless an investor chooses to continue the conversation.
You receive a gift: active, real-time diligence. Following the meeting, we compile the results into a 7–10 page diligence feedback report containing both quantitative and qualitative insights. Clear next steps are communicated—whether we are passing or continuing diligence—so you always know exactly where we stand.